Exploiting the synergy of registered drugs Rifampicin and Albendazole to shorten the treatment duration of Macrofilaricide for the cure of Onchocerciasis in areas co-endemic with Loiasis: A phase II Clinical Trial study
TMA2019SFP-2814
EDCTP2
Senior Fellowship Plus (SFP)
Department | Institution | Country |
---|---|---|